Other OTC - Delayed Quote • USD
Affymax, Inc. (AFFY)
At close: April 25 at 10:37 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2013) | Next Qtr. (Mar 2014) | Current Year (2013) | Next Year (2014) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.63 | -0.9 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2013) | Next Qtr. (Mar 2014) | Current Year (2013) | Next Year (2014) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 13.68M |
| Low Estimate | 10k | -- | 1.39M | 13.68M |
| High Estimate | 10k | -- | 1.39M | 13.68M |
| Year Ago Sales | 14.8M | 844k | 94.37M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2012 | 3/31/2013 | 6/30/2013 | 9/30/2013 |
|---|---|---|---|---|
| EPS Est. | -0.61 | -0.57 | -0.41 | -0.33 |
| EPS Actual | -0.63 | -0.9 | -0.02 | -0.05 |
| Difference | -0.02 | -0.33 | 0.39 | 0.28 |
| Surprise % | -3.30% | -57.90% | 95.10% | 84.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2013) | Next Qtr. (Mar 2014) | Current Year (2013) | Next Year (2014) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.33 | 0 | -0.97 | -0.7 |
| 30 Days Ago | -0.33 | 0 | -0.97 | -0.7 |
| 60 Days Ago | -0.33 | 0 | -0.97 | -0.7 |
| 90 Days Ago | -0.33 | 0 | -0.97 | -0.7 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2013) | Next Qtr. (Mar 2014) | Current Year (2013) | Next Year (2014) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AFFY | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 2.60% |
| Next Qtr. | -- | -- | -- | 13.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | 7.00% | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | McNicoll Lewis Vlak: Sell | 3/19/2013 |
| Downgrade | Lazard: Buy to Neutral | 2/26/2013 |
| Downgrade | JMP Securities: Market Outperform to Market Underperform | 2/25/2013 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/25/2013 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/25/2013 |
| Downgrade | Stifel: Buy to Hold | 2/25/2013 |
Related Tickers
AAGH America Great Health
0.0008
-1.71%
XBIO Xenetic Biosciences, Inc.
3.7759
-0.11%
COCP Cocrystal Pharma, Inc.
1.5100
+0.67%
OGEN Oragenics, Inc.
1.0600
-2.75%
TENX Tenax Therapeutics, Inc.
3.6000
+1.12%
IGC IGC Pharma, Inc.
0.4300
-2.05%
ARVN Arvinas, Inc.
31.60
-2.89%
BPMC Blueprint Medicines Corporation
90.73
-1.66%
MRVI Maravai LifeSciences Holdings, Inc.
7.58
-1.17%
RIGL Rigel Pharmaceuticals, Inc.
1.1000
-2.22%